1. Lamaizon CS, Cecchini D, Brizuela M, Copertari G, et al.
   Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.
   AIDS 2026;40:1587-1590.
   


2. Rodrigues K, Bahrambegi R, Reid M.
   Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.
   AIDS 2026;40:1585-1587.
   


3. Varadarajan M, Byrne R, Al-Hussaini A, Halliday B, et al.
   The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.
   AIDS 2026;40:1582-1585.
   


4. Buzon L, Bernal-Morell E, Montes ML, Gisbert L, et al.
   Rethinking HIV resistance in the era of long-acting therapy: from isolated events to durable exposure.
   AIDS 2026;40:1577-1581.
   


5. Mujugira A, Nsubuga R, Nakyanzi A, Bagaya M, et al.
   Same-day initiation of tenofovir alafenamide-based pre-exposure prophylaxis with drug-level feedback for transgender women in Uganda.
   AIDS 2026;40:1508-1516.
   


6. Shuaib M, Odayar J, Phillips TK, Malaba TR, et al.
   Viral suppression in models of care for improving engagement of antiretroviral therapy in postpartum women living with HIV.
   AIDS 2026.
   


7. Panneer N, France AM, Billock RM, Islam MH, et al.
   Clusters and outbreaks contribute disproportionately to future HIV transmission in the United States.
   AIDS 2026.
   


8. Tagliaferri Rael C, Das D, Giguere R, Porter J, et al.
   Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa.
   AIDS Res Hum Retroviruses 2026.
   


9. Diarra A, Vignier N, Tantet C, Petit B, et al.
   When Choosing Antiretroviral Therapy Meets Immigration Policy: An Ethical Analysis.
   Clin Infect Dis 2026.
   


10. Chandra C, Maloney KM, Le Guillou A, Hoover KW, et al.
    Modeling the Potential Impact of Scaling Up Event-Driven PrEP Among Gay, Bisexual, and Other Men who have Sex with Men.
    J Acquir Immune Defic Syndr 2026.
    


11. Zou S, Yan Y, Ye J, Liu J, et al.
    Cellular immune response of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr 2026.
    


12. Brault MA, Ahonkhai AA, Frndak S, Colt S, et al.
    Factors associated with viral suppression and antiretroviral therapy adherence among adolescents and young adults living with HIV in the African Cohort Study.
    J Acquir Immune Defic Syndr 2026.
    


13. Fusco P, Russo A.
    Once-weekly oral islatravir plus lenacapavir: clinical considerations for individualized use.
    J Acquir Immune Defic Syndr 2026.
    


14. Wattiau P, Omar SV, Joseph L, Demoitie MA, et al.
    Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.
    J Infect Dis 2026.
    


15. Khayargoli P, Grace D, Cox J, de Pokomandy A, et al.
    HPV vaccine effectiveness against prevalent HPV by age, years sexually active before vaccination, and HIV status in gay, bisexual, and other men who have sex with men, 2019-2021.
    J Infect Dis 2026.
    


16. Adzemovic T, Nalintya E, Onencan P, Enock O, et al.
    Concordance Between Fingerprick and Venous Whole Blood CD4 Counts Using the Visitect CD4 Advanced disease platform.
    J Infect Dis 2026.
    


17. Farcet MR, Karbiener M, Kreil TR.
    Serosurvey for Antibodies to Bourbon Virus and Related Thogotoviruses in Immunoglobulin Lots Obtained From Human Plasma Collected in the United States and Europe.
    J Infect Dis 2026.
    


18. Rangaraj A, Ford N.
    Simplifying CD4 testing to support advanced HIV disease care.
    J Infect Dis 2026.
    


19. Kim SJ, Janssens J, Isbell C, Wedrychowski A, et al.
    HIV DNA and transcription before and after ART in natural controllers compared to noncontrollers.
    J Virol 2026.
    


20. Muhindo Muyisa R, Kavugho Loando V, Kavira Kavulivwa L, Katsuva Ngowire D, et al.
    Beyond Ebola: armed conflict and humanitarian funding cuts threaten control of malaria, TB and HIV in eastern DRC.
    Nat Med 2026.
    


21. Mussi-Pinhata MM, Yamamoto AY, Hofer CB, Watts J, et al.
    Cytomegalovirus Shedding in Brazilian Pregnant Women Living With HIV on Combination Antiretrovirals and CMV Infection in Infants.
    Pediatr Infect Dis J 2026.
    

Display articles in

• Abstract format